Evaluation of Pharmacokinetics, Safety and Tolerability of a Single Dose of Prucalopride, in Subjects With Moderate and Severe Hepatic Impairment, in Comparison With Healthy Subjects.

Trial Profile

Evaluation of Pharmacokinetics, Safety and Tolerability of a Single Dose of Prucalopride, in Subjects With Moderate and Severe Hepatic Impairment, in Comparison With Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Apr 2012

At a glance

  • Drugs Prucalopride (Primary)
  • Indications Constipation; Postoperative ileus
  • Focus Pharmacokinetics
  • Sponsors Shire-Movetis NV
  • Most Recent Events

    • 18 Apr 2012 Actual end date changed from 1 Apr 2011 to 1 Feb 2011 as reported by ClinicalTrials.gov.
    • 18 Apr 2012 Actual initiation date changed from 2 Jun 2010 to 1 May 2010 as reported by ClinicalTrials.gov.
    • 11 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top